Recombinant coagulation factor replacement

This page covers all Recombinant coagulation factor replacement drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Factor IX (coagulation cascade), Coagulation Factor IX (FIX).

Targets

Factor IX (coagulation cascade) · Coagulation Factor IX (FIX)

Marketed (1)

• FIX · Bioverativ Therapeutics Inc. · Hematology
  FIX is a recombinant coagulation Factor IX that replaces deficient or dysfunctional Factor IX to restore the intrinsic coagulation pathway in patients with hemophilia B.

Phase 3 pipeline (1)

• rFIX · Wyeth is now a wholly owned subsidiary of Pfizer · Hematology
  rFIX is a recombinant human coagulation factor IX that replaces deficient or dysfunctional Factor IX to restore blood clotting ability in hemophilia B patients.